Correspondence 0001493152-23-045921 from MIRA PHARMACEUTICALS, INC. (MIRA) (CIK 0001904286) (MIRA)

MIRA PHARMACEUTICALS, INC. (MIRA) (CIK 0001904286)
Date: Dec. 22, 2023 · CIK: 0001904286 · Accession: 0001493152-23-045921

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-276118

Date

Dec. 22, 2023

Author

Chief

Form

CORRESP

Company

MIRA PHARMACEUTICALS, INC. (MIRA) (CIK 0001904286)

Letter

MIRA PHARMACEUTICALS, Inc.

N Wolfe Street, Suite 601

Baltimore, Maryland 21205

December 22, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

F Street, N.E.

Washington, D.C. 20549

Attn: Alan Campbell

Re: MIRA Pharmaceuticals, Inc.

Registration Statement on Form S-1

Filed December 18, 2023

File No. 333-276118

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant, MIRA Pharmaceuticals, Inc., hereby requests that the above-referenced Registration Statement on Form S-1 be declared effective at 5:00 p.m., Eastern Standard Time, on Wednesday, December 27, 2023, or as soon as practicable thereafter. The Registrant respectfully requests that you notify Curt Creely of Foley & Lardner LLP of such effectiveness by a telephone call to (813) 225-4122.

Very
truly yours,
mira
pharmaceuticals, Inc.

Show Raw Text

CORRESP
1
filename1.htm

MIRA
PHARMACEUTICALS, Inc.

855
N Wolfe Street, Suite 601

Baltimore,
Maryland 21205

December
22, 2023

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

Office
of Life Sciences

100
F Street, N.E.

Washington,
D.C. 20549

Attn:
Alan Campbell

    Re:
    MIRA
    Pharmaceuticals, Inc.

    Registration
    Statement on Form S-1

    Filed
    December 18, 2023

    File
    No. 333-276118

Ladies
and Gentlemen:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant, MIRA Pharmaceuticals, Inc., hereby requests that
the above-referenced Registration Statement on Form S-1 be declared effective at 5:00 p.m., Eastern Standard Time, on Wednesday, December
27, 2023, or as soon as practicable thereafter. The Registrant respectfully requests that you notify Curt Creely of Foley & Lardner
LLP of such effectiveness by a telephone call to (813) 225-4122.

    Very
    truly yours,

    mira
    pharmaceuticals, Inc.

    By:
    /s/
    Erez Aminov

    Erez
    Aminov

    Chief
    Executive Officer

SecProbe.io